Vertex Pharmaceuticals Incorporated (ETR: VX1)

Germany flag Germany · Delayed Price · Currency is EUR
412.75
+5.05 (1.24%)
Jan 17, 2025, 5:35 PM CET
3.39%
Market Cap 105.60B
Revenue (ttm) 9.53B
Net Income (ttm) -430.19M
Shares Out n/a
EPS (ttm) -1.67
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 59
Average Volume 220
Open 407.90
Previous Close 407.70
Day's Range 407.90 - 412.75
52-Week Range 353.40 - 489.20
Beta 0.46
RSI 49.87
Earnings Date Feb 6, 2025

About Vertex Pharmaceuticals

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age or older; SYMDEKO/SYMKEVI for people with CF for 6 years of age or older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 year or older who have CF with ivacaftor. The company’s pipeline includes VX-522, a CFTR mRNA therapeutic designed to treat the underl... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1989
Employees 5,400
Stock Exchange Deutsche Börse Xetra
Ticker Symbol VX1
Full Company Profile

Financial Performance

In 2023, Vertex Pharmaceuticals's revenue was $9.87 billion, an increase of 10.51% compared to the previous year's $8.93 billion. Earnings were $3.62 billion, an increase of 8.96%.

Financial numbers in USD Financial Statements

News

HHS Challenges Vertex Over Fertility Services Program Tied To Casgevy Gene Therapy, Says Company Is 'Grasping at Straws'

In a court filing on Monday, the Department of Health and Human Services (HHS) challenged Vertex Pharmaceuticals Inc (NASDAQ: VRTX), defending its stance that the company’s proposed fertility service...

4 days ago - Benzinga

Lost Money on Vertex Pharmaceuticals Incorporated(VRTX)? Contact Levi & Korsinsky Regarding an Ongoing Investigation

NEW YORK, NY / ACCESS Newswire / January 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex Pharmaceuticals Incorporated ("Vertex Pharmaceuticals") (NASDAQ...

4 days ago - Accesswire

Lost Money on Vertex Pharmaceuticals Incorporated (VRTX)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky

NEW YORK, NY / ACCESSWIRE / January 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex Pharmaceuticals Incorporated ("Vertex Pharmaceuticals") (NASDAQ:VRTX...

5 days ago - Accesswire

Lost Money on Vertex Pharmaceuticals Incorporated (VRTX)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky

NEW YORK, NY / ACCESSWIRE / January 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex Pharmaceuticals Incorporated ("Vertex Pharmaceuticals") (NASDAQ:VRTX...

5 days ago - Accesswire

Here's How Much $100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today

Vertex Pharmaceuticals (NASDAQ: VRTX) has outperformed the market over the past 10 years by 1.52% on an annualized basis producing an average annual return of 12.68%. Currently, Vertex Pharmaceutical...

6 days ago - Benzinga

Vertex Pharmaceuticals Sets Sight on Expanding Portfolio with Alyftrek Approval, Pain Treatment Progress, and Diabetes Trials

On Sunday, Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) announced multiple program updates, including: In December, the FDA approved Vertex's Alyftrek (vanzacaftor / tezacaftor / deutivacaftor)...

6 days ago - Benzinga

Vertex Pharmaceuticals Sets Sight on Expanding Portfolio with Alyftrek Approval, Pain Treatment Progress, and Diabetes Trials

On Sunday, Vertex Pharmaceuticals Incorporated VRTX announced multiple program updates, including:

6 days ago - Benzinga

Vertex Pharmaceuticals Incorporated Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - VRTX

NEW YORK, NY / ACCESSWIRE / January 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex Pharmaceuticals Incorporated ("Vertex Pharmaceuticals") (NASDAQ:VRTX...

6 days ago - Accesswire

Vertex Pharmaceuticals Incorporated Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - VRTX

NEW YORK, NY / ACCESSWIRE / January 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex Pharmaceuticals Incorporated ("Vertex Pharmaceuticals") (NASDAQ:VRTX...

6 days ago - Accesswire

Lost Money on Vertex Pharmaceuticals Incorporated(VRTX)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky

NEW YORK, NY / ACCESSWIRE / January 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex Pharmaceuticals Incorporated ("Vertex Pharmaceuticals") (NASDAQ:VRTX...

7 days ago - Accesswire

Lost Money on Vertex Pharmaceuticals Incorporated(VRTX)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky

NEW YORK, NY / ACCESSWIRE / January 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex Pharmaceuticals Incorporated ("Vertex Pharmaceuticals") (NASDAQ:VRTX...

7 days ago - Accesswire

Vertex Pharmaceuticals Inc (VRTX) Announces Significant Program Updates Ahead of 2025

Vertex Pharmaceuticals Inc (VRTX) Announces Significant Program Updates Ahead of 2025

8 days ago - GuruFocus

Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced multiple program updates ahead of upcoming investor meetings in January, including the company’s scheduled webcast from the 43rd Annu...

8 days ago - Wallstreet:Online

Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced multiple program updates ahead of upcoming investor meetings in January, including the company's scheduled w...

8 days ago - Business Wire

Pfizer Is 'Too Low To Sell,' Jim Cramer Says: Recommends Nvidia For Robotics Exposure

Pfizer Inc (NYSE: PFE) shares are just "too low to sell," according to Jim Cramer , host of CNBC’s " Mad Money Lightning Round ." Hold the stock and let "the dividend do the job," Cramer advises, pre...

10 days ago - Benzinga

Zai Lab Ltd (ZLAB) Partners with Vertex Pharmaceuticals for Povetacicept Development in Asia

Zai Lab Ltd (ZLAB) Partners with Vertex Pharmaceuticals for Povetacicept Development in Asia

10 days ago - GuruFocus

Vertex Pharmaceuticals and Zai Lab Announce Strategic Collaboration for Povetacicept in Asia

Vertex Pharmaceuticals and Zai Lab Announce Strategic Collaboration for Povetacicept in Asia

10 days ago - GuruFocus

Vertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Zai Lab Limited (Nasdaq: ZLAB; HKEX: 9688) today announced an exclusive collaboration and license agreement for the development and commercializa...

10 days ago - Wallstreet:Online

Zai Lab and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan region and Singapore

Zai Lab Limited (Nasdaq: ZLAB; HKEX: 9688) and Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced an exclusive collaboration and license agreement for the development and commercializa...

10 days ago - Wallstreet:Online

Vertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore

BOSTON & SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Zai Lab Limited (Nasdaq: ZLAB; HKEX: 9688) today announced an exclusive collaboration and ...

10 days ago - Business Wire

Zai Lab and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan region and Singapore

SHANGHAI & CAMBRIDGE, Mass. & BOSTON--(BUSINESS WIRE)--Zai Lab Limited (Nasdaq: ZLAB; HKEX: 9688) and Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced an exclusive collaboration and ...

10 days ago - Business Wire

Levi & Korsinsky Announces an Investigation on Behalf of Vertex Pharmaceuticals Incorporated (VRTX) Shareholders Who May Have Been Affected by Fraud

NEW YORK, NY / ACCESSWIRE / January 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex Pharmaceuticals Incorporated ("Vertex Pharmaceuticals") (NASDAQ:VRTX...

10 days ago - Accesswire